Chest pain secondary prevention: Difference between revisions

Jump to navigation Jump to search
Line 6: Line 6:
Secondary prevention of chest pain depend on the cause for instance, [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. myocarditis secondary prevention include, [https://www.wikidoc.org/index.php/Clinical clinical] evaluation, [https://www.wikidoc.org/index.php/ECG ECG], and [https://www.wikidoc.org/index.php/Echocardiography echocardiography]. [https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan]. secondary prevention of chest pain caused by GERD avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.
Secondary prevention of chest pain depend on the cause for instance, [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. myocarditis secondary prevention include, [https://www.wikidoc.org/index.php/Clinical clinical] evaluation, [https://www.wikidoc.org/index.php/ECG ECG], and [https://www.wikidoc.org/index.php/Echocardiography echocardiography]. [https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan]. secondary prevention of chest pain caused by GERD avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.
==Secondary Prevention==
==Secondary Prevention==
Secondary prevention of chest pain depend on the cause:
[[Secondary prevention]] of chest pain depend on the cause:


*[[Secondary prevention]] of chest pain due to [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating [https://www.wikidoc.org/index.php/Coronary_heart_disease_risk_factors Category I] risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, [https://www.wikidoc.org/index.php/Coronary_heart_disease_secondary_prevention here].
*[[Secondary prevention]] of chest pain due to [https://www.wikidoc.org/index.php/Chronic_stable_angina_definition chronic stable angina], risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating [https://www.wikidoc.org/index.php/Coronary_heart_disease_risk_factors Category I] risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, [https://www.wikidoc.org/index.php/Coronary_heart_disease_secondary_prevention here].


*[https://www.wikidoc.org/index.php/Secondary_prevention secondary prevention] of myocarditis include:<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal
*[https://www.wikidoc.org/index.php/Secondary_prevention Secondary prevention] of [[myocarditis]] include:<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal
  | author = [[C. L. Miklozek]], [[E. M. Kingsley]], [[C. S. Crumpaker]], [[J. F. Modlin]], [[H. D. Royal]], [[P. C. Come]], [[R. Mark]] & [[W. H. Abelmann]]
  | author = [[C. L. Miklozek]], [[E. M. Kingsley]], [[C. S. Crumpaker]], [[J. F. Modlin]], [[H. D. Royal]], [[P. C. Come]], [[R. Mark]] & [[W. H. Abelmann]]
  | title = Serial cardiac function tests in myocarditis
  | title = Serial cardiac function tests in myocarditis
Line 27: Line 27:
**[https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan], [https://www.wikidoc.org/index.php/Nuclear nuclear assessment] in [https://www.wikidoc.org/index.php/Patients patients] that [https://www.wikidoc.org/index.php/Echocardiography echocardiography] is undiagnostic
**[https://www.wikidoc.org/index.php/CMR CMR], [https://www.wikidoc.org/index.php/Cardiac cardiac] [https://www.wikidoc.org/index.php/CT_scan CT scan], [https://www.wikidoc.org/index.php/Nuclear nuclear assessment] in [https://www.wikidoc.org/index.php/Patients patients] that [https://www.wikidoc.org/index.php/Echocardiography echocardiography] is undiagnostic
**[https://www.wikidoc.org/index.php/Patients Patients] should undergo [https://www.wikidoc.org/index.php/Cardiac_function_curve cardiac function] assessment at one and six months and yearly after that.
**[https://www.wikidoc.org/index.php/Patients Patients] should undergo [https://www.wikidoc.org/index.php/Cardiac_function_curve cardiac function] assessment at one and six months and yearly after that.
*[[Secondary prevention]] of GERD include the following:<ref name="pmid15654800">{{cite journal| author=DeVault KR, Castell DO, American College of Gastroenterology| title=Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2005 | volume= 100 | issue= 1 | pages= 190-200 | pmid=15654800 | doi=10.1111/j.1572-0241.2005.41217.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15654800  }}</ref>
*[[Secondary prevention]] of [[GERD]] include the following:<ref name="pmid15654800">{{cite journal| author=DeVault KR, Castell DO, American College of Gastroenterology| title=Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. | journal=Am J Gastroenterol | year= 2005 | volume= 100 | issue= 1 | pages= 190-200 | pmid=15654800 | doi=10.1111/j.1572-0241.2005.41217.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15654800  }}</ref>
**Avoiding foods and beverages that worsen symptoms.
**Avoiding foods and beverages that worsen symptoms.
**[https://www.wikidoc.org/index.php/Smoking_cessation Smoking cessation]
**[https://www.wikidoc.org/index.php/Smoking_cessation Smoking cessation]
Line 34: Line 34:
**Avoid lying down for 3 hours after a meal.
**Avoid lying down for 3 hours after a meal.
**Head raising of the bed while sleeping by securing wood blocks under the bedposts not only extra pillows
**Head raising of the bed while sleeping by securing wood blocks under the bedposts not only extra pillows
*chest pain due to pneumonia can be prevented by smoking cessation, vaccination against pneumococcal, and influenza are the commonly used methods.<ref name="CDC">Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR'' 1999;48(RR-4):1–28. PMID 10366138.</ref>
*chest pain due to [[pneumonia]] can be prevented by [[smoking cessation]], [[vaccination]] against [[pneumococcal]], and [[influenza]] are the commonly used methods.<ref name="CDC">Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR'' 1999;48(RR-4):1–28. PMID 10366138.</ref>





Revision as of 14:07, 26 February 2021

Chest pain Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chest pain from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Chest Pain in Pregnancy

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chest pain secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chest pain secondary prevention

CDC on Chest pain secondary prevention

Chest pain secondary prevention in the news

Blogs on Chest pain secondary prevention

to Hospitals Treating Chest pain secondary prevention

Risk calculators and risk factors for Chest pain secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2] Nuha Al-Howthi, MD[3]

Overview

Secondary prevention of chest pain depend on the cause for instance, chronic stable angina, risk factor modification remains an urgent and essential part of secondary prevention strategy. myocarditis secondary prevention include, clinical evaluation, ECG, and echocardiography. CMR, cardiac CT scan. secondary prevention of chest pain caused by GERD avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.

Secondary Prevention

Secondary prevention of chest pain depend on the cause:

  • Secondary prevention of chest pain due to chronic stable angina, risk factor modification remains an urgent and essential part of secondary prevention strategy. ACC/AHA states that Identifying and, when present, treating Category I risk factors can be an optimal secondary prevention strategy in patients with chronic stable angina. You can read more about general coronary heart disease secondary prevention, here.


You can read in greater detail about each of the risk factor modification topic below by clicking on the link for that topic:

References

  1. Caforio, A. L. P.; Pankuweit, S.; Arbustini, E.; Basso, C.; Gimeno-Blanes, J.; Felix, S. B.; Fu, M.; Helio, T.; Heymans, S.; Jahns, R.; Klingel, K.; Linhart, A.; Maisch, B.; McKenna, W.; Mogensen, J.; Pinto, Y. M.; Ristic, A.; Schultheiss, H.-P.; Seggewiss, H.; Tavazzi, L.; Thiene, G.; Yilmaz, A.; Charron, P.; Elliott, P. M. (2013). "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases". European Heart Journal. 34 (33): 2636–2648. doi:10.1093/eurheartj/eht210. ISSN 0195-668X.
  2. C. L. Miklozek, E. M. Kingsley, C. S. Crumpaker, J. F. Modlin, H. D. Royal, P. C. Come, R. Mark & W. H. Abelmann (1986). "Serial cardiac function tests in myocarditis". Postgraduate medical journal. 62 (728): 577–579. doi:10.1136/pgmj.62.728.577. PMID 3774697. Unknown parameter |month= ignored (help)
  3. DeVault KR, Castell DO, American College of Gastroenterology (2005). "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease". Am J Gastroenterol. 100 (1): 190–200. doi:10.1111/j.1572-0241.2005.41217.x. PMID 15654800.
  4. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-4):1–28. PMID 10366138.

Template:WH Template:WS